| Literature DB >> 29029616 |
Judy Ammerlaan1,2, Harmieke van Os-Medendorp3, Nienke de Boer-Nijhof4, Lieske Scholtus4, Aike A Kruize5, Philomine van Pelt6,7, Berent Prakken7, Hans Bijlsma5.
Abstract
BACKGROUND: A web-based self-management intervention guided by peer-trainers was developed to support young adults' self-management in coping with Juvenile Idiopathic Arthritis (JIA). To investigate its effectiveness, a randomized controlled trial (RCT) was conducted. In addition, the content of the chat and participants' goals were studied to identify underlying processes.Entities:
Keywords: Effectiveness; Experiences; Juvenile idiopathic arthritis; Peer-guided; Self-management; Short-term; Web-based intervention; Young adults
Mesh:
Year: 2017 PMID: 29029616 PMCID: PMC5640921 DOI: 10.1186/s12969-017-0201-1
Source DB: PubMed Journal: Pediatr Rheumatol Online J ISSN: 1546-0096 Impact factor: 3.054
Themes and content of the web-based self-management intervention Challenge your arthritis
| Themes | Contents |
|---|---|
| Are you a self-manager? | • introducing yourself, get in touch with the group |
| Friends, family and communication | • communication strategies |
| Feeling blue | • receiving therapies (treatment, medication) |
| Sport and exercises | • being active |
| Relations and Intimacy | • body images and thoughts |
| Having control over your life and arthritis | • evaluation of your personal goals; how to move on? |
Fig. 1Flowchart of the participants
Baseline characteristics of the participants
| Baseline characteristics Intervention versus Control | |||
|---|---|---|---|
| Characteristic | Total group ( | Intervention group ( | Control group ( |
| Gender – female n (%) | 59 (88%) | 29 (83%) | 30 (94%) |
| Age, mean years (SD) | 19.1 (2.7) | 19.2 (2.7) | 19.1 (2.9) |
| Education level completed n (%) | |||
| Primary educationa | 15 (22%) | 10 (29%) | 5 (16%) |
| Intermediate vocational educationb | 35 (52%) | 17 (49%) | 18 (56%) |
| Bachelor or University | 17 (25%) | 8 (23%) | 9 (28%) |
| Civil status n (%) | |||
| Living at home with parents | 53 (79%) | 26 (74%) | 27 (84%) |
| Living independently | 14 (21%) | 9 (26%) | 5 (16%) |
| Marital status n (%) | |||
| Single | 61 (91%) | 32 (91%) | 29 (91%) |
| Living together | 3 (5%) | 1 (2%) | 2 (6%) |
| Married | 3 (5%) | 2 (6%) | 1 (3%) |
| Diagnosed disease n (%) | |||
| Oligo-articular JIA | 14 (21%) | 8 (23%) | 6 (19%) |
| Poly-articular JIA | 24 (36%) | 9 (26%) | 15 (47%) |
| Systemic JIA | 8 (12%) | 6 (17%) | 2 (6%) |
| Other | 21 (31%) | 12 (34%) | 9 (28%) |
| Duration of the disease (years diagnosed, mean, SD) | 10.9 (6.4) | 10.1 (6,3) | 11.8 (6.5) |
| Frequency of internet use n(%) | |||
| (Almost) daily | 62 (93%) | 31 (89%) | 31 (97%) |
| Several times a week | 3 (5%) | 2 (6%) | 1 (3%) |
| Few times a week | 1 (2%) | 1 (3%) | |
| Rarely | 1 (2%) | 1 (3%) | |
| Purpose use internet | |||
| Search health info n(%) | |||
| Not | 3 (5%) | 2 (6%) | 1 (3%) |
| Yes, one single time | 30 (45%) | 18 (51%) | 12 (38%) |
| Yes, sometimes | 28 (28%) | 11 (31%) | 17 (53%) |
| Frequent | 6 (9%) | 4 (11%) | 2 (6%) |
| Forum visit health/arthritis | |||
| Not | 47 (70%) | 23 (66%) | 24 (75%) |
| Yes, one single time | 12 (18%) | 7 (20%) | 5 (16%) |
| Yes, sometimes | 6 (9%) | 4 (11%) | 2 (6%) |
| Frequent | 2 (3%) | 1 (3%) | 1 (3%) |
| Chat/e-mail with someone with arthritis | |||
| Not | 55 (82%) | 27 (77%) | 28 (88%) |
| Yes, one single time | 5 (7%) | 4 (11%) | 1 (3%) |
| Yes, sometimes | 2 (3%) | 2 (6%) | |
| Frequent | 5 (8%) | 2 (6%) | 3 (9%) |
| Visit weblog patient | |||
| Not | 55 (82%) | 30 (86%) | 25 (78%) |
| Yes, one single time | 9 (13%) | 2 (6%) | 7 (22%) |
| Yes, sometimes | 2 (3%) | 2 (6%) | |
| Frequent | 1 (2%) | 1 (3%) | |
| Relevance internet in relation | |||
| disease, Scale 1–10 (mean) ( | 3.4 (2.5) | 3.1 (2.7) | 3.7 (2.1) |
| peer support, Scale 1–10 (mean) | 3.0 (2.5) | 3.1 (2.6) | 3.0 (2.5) |
SD standard deviation
aLower vocational education, lower general secondary education
bhigher general secondary education, pre-university education
Results linear mixed models for Dutch-ASES, HAQ-DI, pain, well-being, fatigue, disease-activity and heiQ
| Source | F | Sig. | |
|---|---|---|---|
| Dutch Arthritis Self-efficacy Scale | Intercept | 1322.47 | 0 |
| T | 0.51 | 0.61 | |
| group | 0.17 | 0.68 | |
| T * group | 2.07 | 0.14 | |
| Dutch Consensus Health Assessment Questionnaire (HAQ-DI) | Intercept | 68.32 | 0 |
| T | 0.21 | 0.81 | |
| group | 0.01 | 0.93 | |
| T * group | 1.26 | 0.29 | |
| Perceived pain | Intercept | 141.02 | 0 |
| T | 1.34 | 0.27 | |
| group | 0.28 | 0.60 | |
| T * group | 0.25 | 0.78 | |
| Perceived well-being | Intercept | 386.33 | 0 |
| T | 0.88 | 0.42 | |
| group | 0.73 | 0.40 | |
| T * group | 2.50 | 0.09 | |
| Perceived fatigue | Intercept | 401.63 | 0 |
| T | 1.63 | 0.21 | |
| group | 0.43 | 0.51 | |
| T * group | 0.21 | 0.81 | |
| Perceived disease activity | Intercept | 146.02 | 0 |
| T | 1.45 | 0.24 | |
| group | 0.16 | 0.69 | |
| T * group | 2.12 | 0.13 | |
| Health Education Impact Questionnaire (heiQ) | |||
| Health directed activity | Intercept | 2011.89 | 0 |
| T | 0.33 | 0.72 | |
| group | 1.15 | 0.29 | |
| T * group | 1.66 | 0.20 | |
| Positive and active engagement in life | Intercept | 3936.64 | 0 |
| T | 0.05 | 0.95 | |
| group | 1.61 | 0.21 | |
| T * group | 0.61 | 0.55 | |
| Emotional distress | Intercept | 909.73 | 0 |
| T | 0.21 | 0.81 | |
| group | 0.02 | 0.90 | |
| T * group | 0.43 | 0.66 | |
| Self-monitoring and insight | Intercept | 6216.50 | 0 |
| T | 1.39 | 0.26 | |
| group | 0.83 | 0.37 | |
| T * group | 0.92 | 0.40 | |
| Constructive attitude and approaches | Intercept | 3941.58 | 0 |
| T | 0.17 | 0.85 | |
| group | 0.08 | 0.78 | |
| T * group | 0.91 | 0.41 | |
| Skills and technique acquisition | Intercept | 2534.79 | 0 |
| T | 1.06 | 0.35 | |
| group | 0.70 | 0.41 | |
| T * group | 1.26 | 0.29 | |
| Social integration and support | Intercept | 2328.77 | 0 |
| T | 1.22 | 0.31 | |
| group | 0.50 | 0.48 | |
| T * group | 1.15 | 0.32 | |
| Health service navigation | Intercept | 2907.22 | 0 |
| T | 0.25 | 0.78 | |
| group | 2.29 | 0.14 | |
| T * group | 1.83 | 0.17 |
F statistic, T Time, T *group interaction time and group, Sig significance
Results on Dutch Arthritis Self-efficacy Scale (Dutch-ASES), Pain, Wellbeing, Fatigue, Disease Activity, HAQ-DI, HeiQ, based on linear mixed models
| Intervention group | Control group | |
|---|---|---|
| Mean (95% CI) | Mean (95% CI) | |
| Dutch-Arthritis Self-efficacy Scalea | ||
| T0 | 6.67 (6.11–7.23) | 6.99 (6.38–7.59) |
| T1 | 6.67 (6.41–7.54) | 6.80 (6.17–7.40) |
| T2 | 6.51 (5.88–7.15) | 6.84 (6.19–7.50) |
| Perceived Painb | ||
| T0 | 3.19 (2.39–3.98) | 3.06 (2.23–3.89) |
| T1 | 3.59 (2.69–4.50) | 3.11 (2.15–4.07) |
| T2 | 3.65 (2.76–4.55) | 3.38 (2.44–4.32) |
| Perceived Wellbeingb | ||
| T0 | 4.59 (3.82–5.36) | 4.24 (3.44–5.03) |
| T1 | 4.93 (4.25–5.62) | 4.03 (3.29–4.76) |
| T2 | 4.12 (3.28–4.96) | 4.24 (3.36–5.12) |
| Perceived Fatigueb | ||
| T0 | 5.36 (4.55–6.16) | 5.05 (4.21–5.89) |
| T1 | 5.45 (4.66–6.23) | 4.95 (4.11–5.79) |
| T2 | 4.94 (4.09–5.79) | 4.75 (3.86–5.64) |
| Perceived Disease Activityb | ||
| T0 | 3.31 (2.57–4.06) | 3.01 (2.23–3.79) |
| T1 | 3.70 (2.81–4.58) | 3.02 (2.08–3.97) |
| T2 | 3.42 (2.49–4.36) | 3.73 (2.75–4.71) |
| Dutch Consensus Health Assessment Questionnaire (HAQ-DI)c | ||
| T0 | 0.66 (0.46–0.87) | 0.62 (0.40–0.85) |
| T1 | 0.67 (0.44–0.90) | 0.59 (0.34–0.83) |
| T2 | 0.62 (0.37–0.87) | 0.70 (0.44–0.97) |
| Health Education Impact Questionnaire (heiQ)d | ||
| Health directed activity | ||
| T0 | 2.98 (2.78–3.18) | 2.94 (2.72–3.16) |
| T1 | 3.13 (2.92–3.33) | 2.86 (2.64–3.07) |
| T2 | 3.08 (2.85–3.32) | 2.96 (2.72–3.21) |
| Positive and active engagement in life | ||
| T0 | 3.25 (3.12–3.38) | 3.18 (3.04–3.32) |
| T1 | 3.30 (3.13–3.47) | 3.11 (2.93–3.29) |
| T2 | 3.28 (3.09–3.47) | 3.16 (2.96–3.36) |
| Emotional distress | ||
| T0 | 2.00 (1.84–2.16) | 1.97 (1.79–2.14) |
| T1 | 1.93 (1.73–2.12) | 1.99 (1.78–2.20) |
| T2 | 1.99 (1.74–2.24) | 2.01 (1.75–2.27) |
| Selfmonitoring and insight | ||
| T0 | 2.97 (2.84–3.11) | 3.01 (2.87–3.16) |
| T1 | 3.17 (3.01–3.32) | 3.04 (2.88–3.20) |
| T2 | 3.11 (2.96–3.25) | 2.99 (2.84–3.13) |
| Constuctive attitude and approaches | ||
| T0 | 3.29 (3.14–3.43) | 3.33 (3.17–3.49) |
| T1 | 3.34 (3.16–3.51) | 3.23 (3.05–3.41) |
| T2 | 3.28 (3.10–3.47) | 3.26 (3.06–3.45) |
| Skills and technique acquisition | ||
| T0 | 2.83 (2.65–3.00) | 2.85 (2.66–3.04) |
| T1 | 3.00 (2.81–3.20) | 2.81 (2.61–3.01) |
| T2 | 3.02 (2.80–3.23) | 2.90 (2.68–3.11) |
| Social integration and support | ||
| T0 | 3.10 (2.91–3.29) | 3.11 (2.90–3.31) |
| T1 | 3.20 (3.01–3.39) | 3.10 (2.90–3.30) |
| T2 | 3.15 (2.93–3.37) | 2.97 (2.74–3.20) |
| Health service navigation | ||
| T0 | 3.16 (3.01–3.31) | 3.12 (2.96–3.29) |
| T1 | 3.28 (3.09–3.46) | 3.03 (2.84–3.23) |
| T2 | 3.31 (3.10–3.52) | 3.06 (2.84–3.28) |
T0 baseline, T1 3 months after baseline, T2 6 months after baseline
ameasured on a scale from 1 to 10 (1 (very unconfident) to 10 (highly confident)
bmeasured on a NRS scale from 0 to 10 (the higher the score, the more pain, fatigue or disease activity and the worse general well-being)
cmeasured on a scale from 0 to 3 (0 (no effort) to 3 (impossible)
dmeasured on a scale from 1 to 4 (1 (not all true) to 4 (exactly true)
Absenteeism, health care use and medication use
| Intervention group | Control group | |||
|---|---|---|---|---|
| n | n | |||
| Absenteeism of school/work (days, previous month) | ||||
| T1: median (min-max)a | 0.00 (0–10) | 30 | 0.00(0–10) | 27 |
| T2: median (min-max)b | 0.00 (0–20) | 25 | 0.00(0–30) | 24 |
| Frequency of health use (whole period) | ||||
| Consultation Pediatrician/rheumatologist, median (min-max) | 3 (0–11) | 3.5 (0–28) | ||
| Consultation Transition clinical nurse, median (min-max) | 1 (0–7) | 0 (0–10) | ||
| Day-care center, median (min-max) | 0 (0–11) | 0 (0–8) | ||
| Medication use | ||||
| Non Steroid Anti-rheumatic Drug (NSAID) | ||||
| T0: n (%) | 12(34.3%) | 35 | 9(28.1%) | 32 |
| T1: n (%) | 15(42.9%) | 35 | 10(31.3%) | 32 |
| T2: n (%) | 12(34.3%) | 35 | 8(25.0%) | 32 |
| Disease Modifying Anti Rheumatic Drug (DMARD) | ||||
| T0: n (%) | 19(54.3%) | 35 | 16(50.0%) | 32 |
| T1: n (%) | 19(54.3%) | 35 | 15(46.9%) | 32 |
| T2: n (%) | 16(45.7%) | 35 | 11(34.4%) | 32 |
| Biologicals | ||||
| T0: n (%) | 4(11.4%) | 35 | 10(31.3%) | 32 |
| T1: n (%) | 7(20%) | 35 | 10(31.3%) | 32 |
| T2: n (%) | 7(20%) | 35 | 8(25%) | 32 |
| Medication to reduce pain (paracetamol) | ||||
| T0: n (%) | 6(17.1%) | 35 | 5(15.6%) | 32 |
| T1: n (%) | 2(5.7%) | 35 | 4(12.5%) | 32 |
| T2: n (%) | 2(5.7%) | 35 | 5(15.6%) | 32 |
aMann-Whitney U (Asymp.Sig (2-tailed)) = 313.50 (0.09)
bMann-Whitney U (Asymp.Sig (2-tailed)) = 284.00 (0.69)